Bill
H 2432
Overview: H 2432 - An Act to reduce incidence and death from pancreatic cancerPurpose and Intent: This bill aims to improve early detection, treatment, and outcomes for pancreatic
Overview: H 2432 - An Act to reduce incidence and death from pancreatic cancer
Purpose and Intent: This bill aims to improve early detection, treatment, and outcomes for pancreatic cancer, one of the deadliest forms of the disease.
Key Provisions:
- Establishes a Pancreatic Cancer Early Detection and Treatment Program within the Department of Public Health.
- Mandates insurance coverage for comprehensive pancreatic cancer screening for high-risk individuals.
- Provides funding for research grants to develop innovative early detection methods and treatment approaches.
- Requires the collection and analysis of statewide data on pancreatic cancer incidence, mortality, and outcomes.
- Directs the Department of Public Health to conduct public awareness campaigns to educate the public on risk factors and screening recommendations.
Affected Parties and Impacts:
- Individuals at high risk of developing pancreatic cancer would have increased access to early detection screening.
- Researchers and healthcare providers would benefit from additional funding and data to advance pancreatic cancer care.
- The general public would be better informed about pancreatic cancer through public awareness efforts.
- Insurance providers would be required to cover comprehensive pancreatic cancer screening for high-risk individuals.
Procedural and Timeline Considerations:
The bill has been reported favorably by the committee and referred to the Committee on Health Care Financing for further consideration. If passed, the new programs and requirements would be implemented over the course of the next 12-18 months.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
